NCT00004328View on ClinicalTrials.gov

Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

December 31, 1992

Conditions
Pseudohypoaldosteronism
Interventions
DRUG

enalapril

DRUG

polystyrene sulfonate

All Listed Sponsors
collaborator

University of Texas

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004328 - Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I | Biotech Hunter | Biotech Hunter